Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.

We evaluated fleroxacin, a newer fluoroquinolone, against isolates from sputum from patients with cystic fibrosis. These isolates included rough and mucoid Pseudomonas aeruginosa, Pseudomonas cepacia, Staphylococcus aureus, Haemophilus influenzae, and Escherichia coli. Selected isolates were tested...

Полное описание

Библиографические подробности

Опубликовано в::	Antimicrob Agents Chemother
Главные авторы:	Akaniro, J C, Vidaurre, C E, Stutman, H R, Marks, M I
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1990
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171958/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2127170/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.10.1880
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!